From: The optimal screening interval for gastric cancer using esophago-gastro-duodenoscopy in Japan
<40 | 40-49 | 50-59 | 60-69 | ≥70 | Total | |
---|---|---|---|---|---|---|
Adenocarcinoma | 0 | 0 | 7 | 11 | 6 | 24 |
MALT * lymphoma | 0 | 0 | 3 | 2 | 1 | 6 |
Signet cell carcinoma | 0 | 3 | 1 | 0 | 0 | 4 |
Carcinoid | 0 | 0 | 1 | 0 | 0 | 1 |
Total | 0 | 3 | 12 | 13 | 7 | 35 |